How many institutions held SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q2 2021?

95 institutional investors reported SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q2 2021. Use the holders table for investor-level position and value details.

Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Q: What does CUSIP 87184Q107 represent in this 13F holders report?

CUSIP 87184Q107 is the security identifier for SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 87184Q107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 27,995,500
Total 13F shares: 47,939,973
Share change: -12,980,110
Total reported value: $259,937,712
Put/Call ratio: 223%
Price per share: $5.45
Number of holders: 95
Value change: -$108,395,908
Number of buys: 63
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 87184Q107?
CUSIP 87184Q107 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 87184Q107:

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	32%	9,015,112	$67,433,000	—	31 Mar 2021	13F
ARK Investment Management LLC	13F	Company	28%	7,711,724	$57,684,000	—	31 Mar 2021	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	21%	5,785,036	$43,272,000	—	31 Mar 2021	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	18%	5,166,290	$38,644,000	—	31 Mar 2021	13F
Amova Asset Management Americas, Inc.	13F	Company	18%	5,042,009	$37,714,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	15%	4,167,964	$31,175,000	—	31 Mar 2021	13F
Ally Bridge Group (NY) LLC	13F	Company	11%	3,139,895	$23,486,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	9.8%	2,732,424	$20,438,000	—	31 Mar 2021	13F
Samsara BioCapital, LLC	13F	Company	7.8%	2,189,199	$14,769,000	—	31 Mar 2021	13F
ORBIMED ADVISORS LLC	13F	Company	6.6%	1,837,500	$13,745,000	—	31 Mar 2021	13F
Omega Fund Management, LLC	13F	Company	5.6%	1,562,500	$11,688,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	3.7%	1,025,000	$7,667,000	—	31 Mar 2021	13F
EcoR1 Capital, LLC	13F	Company	3.6%	1,000,000	$7,480,000	—	31 Mar 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.2%	900,000	$6,732,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	3%	833,008	$6,230,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	2.8%	795,345	$5,949,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	2.5%	698,282	$5,223,000	—	31 Mar 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	2.5%	690,167	$5,162,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	2.4%	663,887	$4,966,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.3%	636,920	$4,764,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	1.9%	519,905	$3,890,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	1.3%	374,131	$2,799,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1.3%	363,167	$2,717,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.3%	351,169	$2,627,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	1.1%	295,800	$2,213,000	—	31 Mar 2021	13F
Redmile Group, LLC	13F	Company	0.76%	212,291	$1,588,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.75%	210,375	$1,574,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.6%	168,793	$1,263,000	—	31 Mar 2021	13F
PDT Partners, LLC	13F	Company	0.53%	147,442	$1,103,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.53%	147,352	$1,102,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.52%	146,613	$1,096,000	—	31 Mar 2021	13F
Altium Capital Management LLC	13F	Company	0.45%	126,702	$948,000	—	31 Mar 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.45%	125,000	$935,000	—	31 Mar 2021	13F
ALPS ADVISORS INC	13F	Company	0.4%	111,510	$834,000	—	31 Mar 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.36%	100,000	$748,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.36%	100,000	$748,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.32%	90,439	$676,000	—	31 Mar 2021	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.32%	90,381	$676,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.31%	85,400	$639,000	—	31 Mar 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.3%	83,447	$624,000	—	31 Mar 2021	13F
Palo Alto Investors LP	13F	Company	0.29%	80,600	$603,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	0.28%	77,044	$577,000	—	31 Mar 2021	13F
Squarepoint Ops LLC	13F	Company	0.27%	75,730	$566,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.25%	71,175	$532,000	—	31 Mar 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.23%	64,830	$485,000	—	31 Mar 2021	13F
QS Investors, LLC	13F	Company	0.23%	64,000	$479,000	—	31 Mar 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.23%	63,108	$472,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.2%	56,187	$420,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.17%	46,698	$349,000	—	31 Mar 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.16%	44,408	$331,000	—	31 Mar 2021	13F

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q2 2021

As of 30 Jun 2021, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,939,973 shares. The largest 10 holders included FMR LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., Ally Bridge Group (NY) LLC, VANGUARD GROUP INC, Omega Fund Management, LLC, Samsara BioCapital, LLC, ORBIMED ADVISORS LLC, Artal Group S.A., and Altium Capital Management LP. This page lists 95 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

-4

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.